Skip to main content

Appili Therapeutics Inc(APLI-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Appili Therapeutics Inc up on Friday (APLI)

Automated Summaries - The Globe and Mail - Fri Apr 19, 4:01PM CDT

In market activity today, Appili Therapeutics Inc shares opened at $0.04 and closed at $0.04. prices ranged from a low of $0.04 to a high of $0.04.

Shares advanced 14.29 percent from the previous day's close of $0.04.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 5011.12, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37775.38 and the Nasdaq Composite closed nasdaq_percentage_change% at 15601.50.

Appili Therapeutics Inc traded under APLI on the Toronto Stock Exchange (TSX).

A total of 99,000 shares was traded during the last trading day, with total trades of 6. On average, Appili Therapeutics Inc has traded 571,659 shares in the last five days and 233,665 year-to-date.

The TSX overall saw 2,775 price advancers against 2,424 declines and 120 unchanged.

During the prior 52 weeks, APLI.TO has traded as high as $0.08 (September 25,2023) and low as $0.03 (March 27,2024). Moreover, in the last 52 weeks, Appili Therapeutics Inc's shares have dipped 0.00%, while this year, they have gained 14.29%.

Following today's trading, Appili Therapeutics Inc has a market capitalization of $4.24 million on a float of 121,266 shares outstanding. Its annual EPS is $-0.04.

Appili Therapeutics Inc is a None company headquartered in Halifax, CAN.

Appili Therapeutics Inc's average recommendation is "Hold" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe